Expertise in
25
conditions

Yutaka U. Takeda

Amagasaki, JP 
Expertise in
25
conditions
Amagasaki, JP 

Overview

Yutaka Takeda practices practicing medicine in Amagasaki, Japan.

Mr. Takeda is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Liver Cancer, Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Hepatectomy, and Endoscopy.

He is actively involved in clinical research, co-authoring 297 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Amagasaki, Japan
Other Locations
Osaka, Japan
Kobe, 6500047, Japan
Ikeda, Japan
Suita, Japan
Japan
Yamaguchi, Japan
Nagoya, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

297 Total Publications

A prospective open label, multicenter phase 2 trial of full-dose gemcitabine and S-1 concurrent with radiation for locally advanced pancreatic ductal adenocarcinoma (BR + UR-LA) (CSGO-HBP-008).
A prospective open label, multicenter phase 2 trial of full-dose gemcitabine and S-1 concurrent with radiation for locally advanced pancreatic ductal adenocarcinoma (BR + UR-LA) (CSGO-HBP-008).
Journal: Surgery today
Published: June 03, 2026

Frequently Asked Questions about Yutaka U. Takeda

Is Yutaka U. Takeda a top-rated expert for Hepatectomy?

MediFind is an objective health platform that identifies experts based on real-world data. Yutaka U. Takeda is classified as an Distinguished expert for Hepatectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yutaka U. Takeda participate in research or clinical trials?

Yes. Yutaka U. Takeda has published 297 articles and abstracts on conditions like Hepatectomy. You can view a list of Yutaka U. Takeda's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Takeda's expertise for a condition
ConditionClose
    View All 20 Advanced Conditions
    View All 52 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile